November 7, 2025 · Form 4 insider transaction
Farrell Michael J. bought 983 shares of ResMed Inc. at $101.64 per share, a transaction worth $99.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.; Includes 74.3412 shares of ResMed stock purchased on October 31, 2025, through the ResMed Employee Stock Purchase Plan.